EUVIMEDEUVIMED entdecken
Open Access

Breast Cancer Incidence Rates in Ghanaian and US Black Women From 2013 Through 2015

Brittny C Davis Lynn, Jonine D Figueroa, Dennis Laryea, Fred Kwame Awittor, Naomi O Ohene Oti, Quiera S Booker, Lawrence Edusei, Nicolas Titiloye, Ernest Adjei, Beatrice Wiafe Addai, Robertson Adjei, Lucy T Afriyie und 14 weitere

JAMA Network Open · 2025

DOI: 10.1001/jamanetworkopen.2025.37160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2025. Verfasst von Brittny C Davis Lynn und 25 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland. Hauptthemen laut MEDLINE: Black or African American, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Uncertainty exists about whether women of West African ancestry have increased rates of estrogen receptor (ER)-negative breast tumors, which commonly have earlier age onsets than ER-positive tumors and are aggressive. High-quality population-based studies in Africa with tumor pathology data are generally unavailable, and there is speculation that younger population age structures may explain the increased frequencies of reported ER-negative tumors.

Objective

To estimate age-standardized and age-specific rates of ER-negative breast cancer among Ghanaian women and non-Hispanic Black and non-Hispanic White women in the US. Design, Setting, and Participants This cross-sectional study used 2013 through 2015 data from a population-based case-control study conducted in 2 metropolitan areas of Ghana, Accra and Kumasi, to estimate ER-specific breast cancer incidence rates among women 18 to 74 years of age. Incidence rates were recovered by applying sampling weights for controls calculated by district, 5-year age groups, and nonresponse rates from the 2010 census-based enumeration area listings. US Breast Cancer Registry data were retrieved from 17 registries in the Surveillance, Epidemiology, and End Results (SEER) program for non-Hispanic Black and non-Hispanic White women with breast cancer 20 to 74 years of age. Analyses were conducted January 2020 through May 2025. Exposures Age, sex, race and ethnicity, ER tumor status, and country (US and Ghana). Main Outcomes and Measures For each of 3 populations, crude, age-standardized, and age-specific breast cancer incidence rates were calculated overall and by ER status.

Results

Analyses were performed for 1071 women (age range, 18-74 years; 468 [51%] ER-negative) in Ghana and 18 321 non-Hispanic Black women (age range, 20-74 years; 5117 [29%] ER-negative) and 103 227 non-Hispanic White women (age range, 20-74 years; 15 040 [15%] ER-negative) in SEER. From 2013 through 2015, ER-negative age-standardized incidence rates were 42.3 (95% CI, 38.7-46.3) per 100 000 women for Ghanaian participants and 43.1 (95% CI, 42.0-44.3) per 100 000 for US non-Hispanic Black women, both higher rates than that of 24.0 (95% CI, 23.6-24.4) per 100 000 for US non-Hispanic White women. ER-positive age-standardized incidence rates were 42.1 (95% CI, 38.4-46.1) per 100 000 women for Ghanaian participants, 105.4 (95% CI, 103.6-107.3) per 100 000 for non-Hispanic Black women, and 128.5 (95% CI, 127.9-129.7) per 100 000 for non-Hispanic White women. Conclusions and Relevance In this cross-sectional study of Ghanaian and US non-Hispanic Black and non-Hispanic White women with breast cancer, age-standardized tumor incidence rates for women with ER-negative tumors in Ghana were similar to those for US non-Hispanic Black women, and both rates were higher than for US non-Hispanic White women. This finding may suggest increased susceptibility requiring elucidation in US non-Hispanic Black and West African populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Black or African AmericanBreast NeoplasmsAdolescentAdultAgedFemaleHumansMiddle AgedYoung AdultCase-Control StudiesCross-Sectional StudiesGhanaIncidenceUnited StatesWhite

Autor:innen und Institutionen

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
  • Usher Institute, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, Scotland.
  • Komfo Anokye Teaching Hospital, Kumasi, Ghana.
  • Korle Bu Teaching Hospital, Accra, Ghana.
  • Peace and Love Hospital, Kumasi, Ghana.
  • Ghana Statistical Service, Accra, Ghana.

Zitieren

APA

Davis Lynn, B. C., Figueroa, J. D., Laryea, D., Awittor, F. K., Oti, N. O. O., Booker, Q. S., Edusei, L., Titiloye, N., Adjei, E., Addai, B. W., Adjei, R., Afriyie, L. T., Yarney, J., Ansong, D., Wiafe, S., Ahearn, T., Vanderpuye, V., Dedey, F., Brinton, L. A., …, & Ghana Breast Health Study Team (2025). Breast Cancer Incidence Rates in Ghanaian and US Black Women From 2013 Through 2015. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.37160

Vancouver

Davis Lynn BC, Figueroa JD, Laryea D, Awittor FK, Oti NOO, Booker QS, et al. Breast Cancer Incidence Rates in Ghanaian and US Black Women From 2013 Through 2015. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.37160

BibTeX
@article{DavisLynn2025,
  author = {Davis Lynn, Brittny C and Figueroa, Jonine D and Laryea, Dennis and Awittor, Fred Kwame and Oti, Naomi O Ohene and Booker, Quiera S and Edusei, Lawrence and Titiloye, Nicolas and Adjei, Ernest and Addai, Beatrice Wiafe and Adjei, Robertson and Afriyie, Lucy T and Yarney, Joel and Ansong, Daniel and Wiafe, Seth and Ahearn, Thomas and Vanderpuye, Verna and Dedey, Florence and Brinton, Louise A and Awuah, Baffour and Clegg-Lamptey, Joe Nat and Abubakar, Mustapha and Garcia-Closas, Montserrat and Biritwum, Richard and Graubard, Barry I and Ghana Breast Health Study Team, Ghana Breast Health Study Team},
  title = {Breast Cancer Incidence Rates in Ghanaian and US Black Women From 2013 Through 2015},
  journal = {JAMA Network Open},
  year = {2025},
  doi = {10.1001/jamanetworkopen.2025.37160}
}
Kostenlos starten →